MSB 3.76% $1.03 mesoblast limited

Diabetes Summitt 2013:Dr. Karen Segal's (Current Senior Vice...

  1. 384 Posts.
    lightbulb Created with Sketch. 5
    Diabetes Summitt 2013:
    Dr. Karen Segal's (Current Senior Vice President, Diabetes and Metabolic Diseases at Mesoblast, Inc) presenting on Tuesday 30th April 13 (b/w 8.00am & 9.45am)

    http://www.gtcbio.com/index.php?option=com_conference&file=program&cn=3rd Diabetes Summit&cid=115

    Dr. Karen Segal's Overview
    Current Senior Vice President, Diabetes and Metabolic Diseases at Mesoblast, Inc.
    - Vice President, Diabetes Clinical Development and Metabolic Therapeutics at Mesoblast LTD
    - Past Clinical Development at Roche ; Senior Medical Director and Scientific Officer for Metabolism; Medical Affairs at sanofi-aventis

    Thanks Khunfoti...much appreciated.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.03
Change
-0.040(3.76%)
Mkt cap ! $1.170B
Open High Low Value Volume
$1.07 $1.07 $1.01 $13.19M 12.81M

Buyers (Bids)

No. Vol. Price($)
3 61090 $1.02
 

Sellers (Offers)

Price($) Vol. No.
$1.03 239558 5
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.